USCAP 2022: The first-ever validation and deployment of AI-solution for gastric cancer detection 

Back

Poster Presentation: USCAP 2022
Study Objective: To clinically validate the performance of an AI-based algorithm in the detection of gastric adenocarcinoma (AdC), high-grade (HG) dysplasia, and Helicobacter pylori (H. pylori), and to implement it in routine clinical workflow.
Conclusions:

  • Galen Gastric (AI) demonstrated accurate detection of a broad range of pathological features in clinical use, including adenocarcinoma, HG dysplasia, H.pylori, being an effective and user-friendly diagnostic support tool for pathologists,
  • The AI-powered Galen Gastric proposes a more cost-effective diagnosis workflow, enabling efficient detection of Helicobacter pylori together with reduction in turnaround time and minimizing ordering of additional stains.
  • AI enables accurate detection of multiple pathological features beyond cancer detection, such as adenoma, LG dysplasia, neuroendocrine neoplasms and more.

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics